M
Marilyn J. Manco-Johnson
Researcher at Anschutz Medical Campus
Publications - 299
Citations - 15823
Marilyn J. Manco-Johnson is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Haemophilia & Population. The author has an hindex of 60, co-authored 290 publications receiving 14200 citations. Previous affiliations of Marilyn J. Manco-Johnson include Brown University & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Marilyn J. Manco-Johnson,Marilyn J. Manco-Johnson,Thomas C. Abshire,Amy D. Shapiro,Brenda Riske,Michele R. Hacker,Ray F. Kilcoyne,J. David Ingram,M L Manco-Johnson,Sharon Funk,Linda J. Jacobson,Leonard A. Valentino,W. Keith Hoots,George R. Buchanan,Donna DiMichele,Michael Recht,Deborah L Brown,Cindy A. Leissinger,Shirley Bleak,Alan R. Cohen,Prasad Mathew,Alison Matsunaga,Desiree Medeiros,Diane J. Nugent,Gregory Thomas,Alexis A. Thompson,Kevin McRedmond,J. Michael Soucie,Harlan Austin,Bruce L. Evatt +29 more
TL;DR: Prophylaxis with recombinant factor VIII can prevent joint damage and decrease the frequency of joint and other hemorrhages in young boys with severe hemophilia A.
Journal ArticleDOI
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
William L. Nichols,M. B. Hultin,Andra H. James,Marilyn J. Manco-Johnson,Robert R. Montgomery,Thomas L. Ortel,Margaret E. Rick,J. E. Sadler,Milton C. Weinstein,Barbara P. Yawn +9 more
TL;DR: This document summarizes needs for further research in VWF, VWD and bleeding disorders, including clinical research to obtain more objective information about bleeding symptoms, advancements in diagnostic and therapeutic tools, and enhancement in the education and training of clinicians and scientists in bleeding and thrombotic disorders.
Journal ArticleDOI
Definitions in hemophilia: communication from the SSC of the ISTH.
Victor S. Blanchette,Nigel S. Key,Rolf Ljung,Marilyn J. Manco-Johnson,H. M. van den Berg,A. Srivastava +5 more
TL;DR: The once-in-a-lifetime opportunity to assess the importance of knowing the carrier and removal status of canine coronavirus in the context of thrombosis and haemostasis is presented.
Journal ArticleDOI
Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children A Systematic Review and Meta-Analysis of Observational Studies
Gili Kenet,Lisa K. Lütkhoff,Manuela Albisetti,Timothy J. Bernard,Mariana Bonduel,Leonardo R. Brandão,Stéphane Chabrier,Anthony K.C. Chan,Gabrielle deVeber,Barbara Fiedler,Heather J. Fullerton,Neil A. Goldenberg,Eric F. Grabowski,Gudrun Günther,Christine Heller,Susanne Holzhauer,Alfonso Iorio,Janna M. Journeycake,Ralf Junker,Fenella J. Kirkham,Fenella J. Kirkham,Karin Kurnik,John K. Lynch,Christoph Male,Marilyn J. Manco-Johnson,Rolf M. Mesters,Paul Monagle,C. Heleen van Ommen,Leslie Raffini,Kevin Rostasy,Paolo Simioni,Ronald Sträter,Guy Young,Ulrike Nowak-Göttl +33 more
TL;DR: It is indicated that thrombophilias serve as risk factors for incident stroke through a meta-analysis of published observational studies and no significant heterogeneity was discerned across studies, and no publication bias was detected.
Journal ArticleDOI
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
Flora Peyvandi,Pier Mannuccio Mannucci,Isabella Garagiola,Amal El-Beshlawy,Mohsen Saleh Elalfy,Vijay Ramanan,Peyman Eshghi,Suresh Hanagavadi,Ramabadran Varadarajan,Mehran Karimi,Mamta Manglani,Cecil Ross,Guy Young,Tulika Seth,Shashikant Apte,Dinesh M Nayak,E. Santagostino,Maria Elisa Mancuso,Adriana C Sandoval Gonzalez,Johnny Mahlangu,Santiago Bonanad Boix,M. Cerqueira,Nadia P. Ewing,Christoph Male,Tarek Owaidah,Veronica Soto Arellano,Nathan L Kobrinsky,Suvankar Majumdar,Rosario Perez Garrido,Anupam Sachdeva,Mindy L. Simpson,Mathew Thomas,Ezio Zanon,Bülent Antmen,Kaan Kavakli,Marilyn J. Manco-Johnson,Monica Martinez,Esperanza Marzouka,Maria Gabriella Mazzucconi,Daniela Neme,Angeles Palomo Bravo,Rogelio Paredes Aguilera,Alessandra Nunes Loureiro Prezotti,Klaus Schmitt,Brian M. Wicklund,Bulent Zulfikar,Frits R. Rosendaal +46 more
TL;DR: Patients treated with plasma-derived factor VIII containing von Willebrand factor had a lower incidence of inhibitors than those treated with recombinant factor VIII, and this association did not change in multivariable analysis.